Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 217704
Company: NEXUS PHARMS

Products on ANDA 217704

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	2MEQ/ML	INJECTABLE;INJECTION	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 217704

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/14/2023	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 217704

POTASSIUM CHLORIDE

INJECTABLE;INJECTION; 2MEQ/ML
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	2MEQ/ML	INJECTABLE;INJECTION	Prescription	No	AP	085870	B BRAUN
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	2MEQ/ML	INJECTABLE;INJECTION	Prescription	Yes	AP	080205	HOSPIRA
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	2MEQ/ML	INJECTABLE;INJECTION	Prescription	No	AP	217704	NEXUS PHARMS
POTASSIUM CHLORIDE IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	2MEQ/ML	INJECTABLE;INJECTION	Prescription	No	AP	088901	FRESENIUS KABI USA
POTASSIUM CHLORIDE IN PLASTIC CONTAINER	POTASSIUM CHLORIDE	2MEQ/ML	INJECTABLE;INJECTION	Prescription	No	AP	088908	FRESENIUS KABI USA